Arvinas hires Berkowitz as CMO

Noah Berkowitz became CMO at Arvinas Inc. (NASDAQ:ARVN), which is developing targeted protein degraders. Berkowitz was SVP, development unit head, hematology at Bristol Myers Squibb Co. (NYSE:BMY) and succeeds Ron Peck, who is leaving Arvinas to pursue other opportunities.

MapLight Therapeutics Inc. hired Bank of America Securities veteran Vishwas Setia to succeed CFO Jonathan Gillis, a move that could signal the CNS disorders company is positioning itself to go public.  MapLight, which has raised at least $275 million in venture cash, has investors that include Novo Holdings A/S, 5AM Ventures and Cowen Healthcare Investments. Gillis will become MapLight’s chief administrative and accounting officer...